Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-436620
Filing Date
2013-11-12
Accepted
2013-11-12 06:13:09
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d612308d10q.htm 10-Q 433292
2 EX-31.1 d612308dex311.htm EX-31.1 9045
3 EX-31.2 d612308dex312.htm EX-31.2 9259
4 EX-32 d612308dex32.htm EX-32 4007
  Complete submission text file 0001193125-13-436620.txt   3296512

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pvct-20130930.xml EX-101.INS 416081
6 XBRL TAXONOMY EXTENSION SCHEMA pvct-20130930.xsd EX-101.SCH 45384
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvct-20130930_cal.xml EX-101.CAL 42004
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvct-20130930_def.xml EX-101.DEF 116186
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvct-20130930_lab.xml EX-101.LAB 313108
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvct-20130930_pre.xml EX-101.PRE 194891
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS PHARMACEUTICALS INC (Filer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-09410 | Film No.: 131206657
SIC: 2834 Pharmaceutical Preparations